@airportroster · Post #904 · 06/12/2022, 09:58 AM
#编号688#墓碑 #GMPORA#GMP 收录时间: 2022.06.12 官网: gmpora.me 群组: @pay_yueluoyun_xyz_Tg 频道: @GMPORAV 商店截图 已被转手。 📖-------> 目录 <------- 📖
TGINSIGHT SIMILAR POSTS
Source channel @githubtrending · Post #15415 · Jan 15
#go#bpf#cncf#cni#containers#ebpf#k8s#kernel#kubernetes#kubernetes_networking#loadbalancing#monitoring#networking#observability#security#troubleshooting#xdp Cilium is an eBPF-based tool for Kubernetes that delivers fast networking, deep visibility, and strong security. It creates simple Layer 3 networks across clusters, handles load balancing to replace kube-proxy, enforces identity-based policies from L3 to L7 (like HTTP or DNS rules), supports service mesh with encryption, and offers Hubble for real-time traffic monitoring. Stable versions like v1.18.6 run on AMD64/AArch64. You gain scalable performance, easier policy management without IP hassles, better troubleshooting, and higher efficiency for large cloud-native apps, cutting costs and boosting reliability. https://github.com/cilium/cilium
Search: #gmp
@airportroster · Post #904 · 06/12/2022, 09:58 AM
#编号688#墓碑 #GMPORA#GMP 收录时间: 2022.06.12 官网: gmpora.me 群组: @pay_yueluoyun_xyz_Tg 频道: @GMPORAV 商店截图 已被转手。 📖-------> 目录 <------- 📖
@OnlineEducation10 · Post #136 · 03/24/2021, 04:01 AM
#Biopharma Institute offers effective and engaging #RemoteLearning solutions in Good Manufacturing Practice and Good Clinical Practice. Earn your #GMP & #GCP professional certification. http://biopharmainstitute.com 👌 Join @OnlineEducation10
@venturevillagewall · Post #3629 · 12/21/2024, 10:22 AM
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences